Opportunity
Simpler Grants.gov #PAR-25-346
NIH NCI Bioengineering Research Grant Solicitation
Buyer
National Institutes of Health
Posted
December 11, 2024
Respond By
January 07, 2028
Identifier
PAR-25-346
NAICS
541715, 541714, 541713
The National Cancer Institute (NCI) at the National Institutes of Health (NIH) is inviting applications for exploratory and developmental bioengineering research grants: - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - Purpose and Scope: - Supports engineering-oriented research projects in biomedical, pre-clinical, or clinical research - Focus on demonstrating feasibility and potential utility of new or improved capabilities - Aims to enhance quality, speed, efficacy, operability, cost-effectiveness, and accessibility in cancer control and related biomedical fields - Eligibility: - Open to educational institutions, nonprofits, businesses, government entities, and other organizations - Funding Details: - Discretionary grant (not a contract for goods or services) - No cost sharing or matching required - Products/Services Requested: - No specific OEMs, vendors, products, or purchase quantities identified - Solicitation is for research proposals, not procurement of tangible goods or defined services - Notable Requirements: - Emphasis on innovative, engineering-driven solutions to biomedical challenges - Projects should address problems in research, clinical care delivery, or accessibility - No administrative or procedural requirements highlighted beyond standard grant eligibility
Description
The National Cancer Institute (NCI) invites applications for exploratory/developmental Bioengineering Research Grants to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. The grant supports engineering-oriented research to address challenges in cancer control and related biomedical fields. Eligible applicants include a wide range of educational institutions, nonprofits, businesses, government entities, and other organizations. The funding instrument is a grant with no cost sharing or matching requirement.